Abantu bathatha izongezelelo ze-chondroitin sulfate ngokuqhelekileyo ukunceda ukulawula i-osteoarthritis, ingxaki eqhelekileyo yamathambo echaphazela i-cartilage ejikeleze amalunga akho.
Abaxhasi bathi xa kuthathwa njengesongezelelo, kwandisa i-synthesis yamacandelo ahlukeneyo e-cartilage ngelixa likhusela ukuphuka kwe-cartilage (4Trusted Source).
Uphononongo lwe-2018 lwezifundo ze-26 lubonise ukuba ukuthatha izongezelelo ze-chondroitin kunokuphucula iimpawu zentlungu kunye nomsebenzi odibeneyo xa kuthelekiswa nokuthatha indawo ye-placebo (i-5Trusted Source).
Uphononongo lwango-2020 lucebisa ukuba inokucothisa ukuqhubeka kwe-OA, ngelixa ikwanciphisa nesidingo samachiza achasene nokudumba, anje nge-ibuprofen, eza neziphumo zawo ebezingalindelekanga (6).
Kwelinye icala, izifundo ezininzi azizange zifumane ubungqina obaneleyo bokucebisa ukuba i-chondroitin inokunceda ukuthomalalisa iimpawu ze-OA, kuquka ukuqina kwamalungu okanye iintlungu (7Trusted Source, 8Trusted Source, 9Trusted Source).
Ii-arhente ezininzi zeengcali, ezifana ne-Osteoarthritis Research Society International kunye ne-American College of Rheumatology, ziyabatyhafisa abantu ekusebenziseni i-chondroitin ngenxa yobungqina obuxubileyo ekusebenzeni kwayo (10Umthombo othembekileyo, i-11Umthombo othembekileyo).
Nangona izongezelelo ze-chondroitin zinokujongana neempawu ze-OA, aziboneleli ngonyango olusisigxina.
Ixesha lokuposa: Aug-13-2022